Mersana Therapeutics (MRSN) Earnings Date & Reports

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MRSN is expected to report earnings to fall 15.79% to -15 cents per share on August 06

Mersana Therapeutics MRSN Stock Earnings Reports

Q2'25

Est.

$-0.16

Q1'25

Est.

$-0.19

Q4'24

Beat

by $0.04

Q3'24

Missed

by $0.18

Q2'24

Missed

by $0.03

The last earnings report on May 15 showed earnings per share of -18 cents, meeting the estimate of -18 cents. With 3.04M shares outstanding, the current market capitalization sits at 48.71M.

View a ticker or compare two or three

Compare

MRSN